Business Wire

FourKites Partners with Sony Network Communications Europe to Help Enterprise Shippers Deliver Exceptional Customer Experience

9.11.2022 11:00:00 EET | Business Wire | Press release

Share

Today, leading supply chain visibility company FourKites announced a partnership with Sony Network Communications Europe. The partnership will integrate data from Visilion — Sony’s real-time cargo and asset tracking solution — with FourKites’ real-time, end-to-end supply chain visibility platform. This collaboration will help enterprise customers solve their most complex use cases. Now, customers will be able to view FourKites’ real-time data for shipments in transit and in the yard, together with Visilion’s granular real-time data on cargo location and condition to provide best-in-class estimated times of arrival (ETAs) and enhanced end-customer experiences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221109005131/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

FourKites Partners with Sony Network Communications Europe to Help Enterprise Shippers Deliver Exceptional Customer Experience (Graphic: Business Wire)

Faced with ongoing global supply chain disruptions — including port congestion, port and rail strikes, global conflicts and more — businesses need more meaningful insights to mitigate preventable delays and damage, and to keep goods moving to their final destinations. Real-time visibility and actionable analytics regarding the location, temperature and status of shipments is critical, particularly for those in the Consumer Packaged Goods, Food & Beverage and Pharmaceutical industries, who ship products that require specific in-transit conditions to maintain quality.

“Businesses today require more high-quality, real-time supply chain data,” said Nimesh Patel, vice president of global alliances and partnerships at FourKites. “The Visilion solution from Sony provides an extra layer of granular data about the contents of containers and status of sensitive and/or temperature-controlled shipments. Our partnership will ensure that this data becomes more accessible than ever to businesses around the world.”

Visilion, Sony’s real-time cargo and asset tracking solution, offers industry-leading shock, tilt and temperature detection capabilities, among others, to ensure that goods are handled properly and maintained at the right temperature and humidity during transit, thereby mitigating losses. This functionality, combined with FourKites’ market-leading Dynamic ETA® across all modes, provides shippers with complete visibility into potential disruptions and product loss for goods in transit. In addition, FourKites’ international tracking capabilities, together with Visilion sensor data, provide an added dimension of granular visibility into ocean containers that often move through complicated, multi-stop journeys.

“FourKites’ shared commitment to industry-leading innovation, product quality and industry collaboration made them the obvious partner for us,” said Erik Lund, Head of Tracking Division, Sony Network Communications Europe. “We look forward to working together to provide our mutual customers with integrated supply chain data to fuel better decision-making and, ultimately, more efficient supply chain operations — in Europe and around the world.”

Over the last year, FourKites has experienced record growth in the European, Middle Eastern and African (EMEA) markets, achieving 97% growth in shipments YoY as of October 2022. The number of customers tracking loads with FourKites in EMEA grew 40% in the same time period, while the number of carriers tracking shipments grew by 50% in the same period.

About FourKites

Leading supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 3 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 210 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,200 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Scott Johnston
European PR Director for FourKites
+31 62 147 8442
scott.johnston@fourkites.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 14:00:00 EEST | Press release

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 13:30:00 EEST | Press release

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye